Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with primary stage I or stage II breast cancer.
- Women who have not yet gone through menopause, as determined using standard breast cancer guidelines.
- People who have not yet started any cancer treatment other than surgery (if chemotherapy before surgery is needed, enrollment must happen before that chemotherapy begins).
- People with a general health and activity level rated at 0 or 1 on a standard medical performance scale, meaning largely able to carry out normal daily activities (confirm with trial site).
- People who are able to understand and fill out various questionnaires or rating scales.
- People who are right-handed.
- Women who could potentially become pregnant must be willing to use a medically approved highly effective form of contraception (such as an intrauterine device, contraceptive pill, or condom) throughout the study.
- People who are willing to sign a consent form and take part in the study voluntarily.
Who may not be able to join:
- People with a nervous system disease, a history of losing consciousness for long periods, a head injury, or any condition that affects thinking or memory.
- People with a current or past history of epilepsy, dementia, or a learning disability.
- People with a past history of mental health or psychiatric conditions.
- People with a previous diagnosis of cancer (other than the current breast cancer).
- People for whom an MRI scan would be unsafe or unsuitable, including those with a pacemaker, defibrillator, hearing implant, insulin pump, medication delivery device, or other metal implants in the body, as well as those with severe fever or a fear of enclosed spaces.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Menghui Yuan, phd, Tang-Du Hospital
Phone: 0086-13519196610
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change of gray matter volume of whole brain; Change of white matter integrity of whole brain.; Change of metabolism of glucose in the brain; Change of functional connectivity of whole brain; Change of verbal learning and memory; Change of information processing speed; Change of executive function; Change of attention, verbal short term and working memory; Change of life quality.; Change of anxiety; Change of depression; Change of fatigue; Change of sleep
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.